Why Most FDA Warning Letters Share a Single — and Fixable — Root Cause

Approximately 61 percent of recent FDA warning letters cite data integrity as a core issue, and this level of regulatory enforcement focus remains steady. Most data integrity violations are not the result of deliberate falsification but rather structural problems in work environments that make compliance difficult. Operators often transcribe data from paper logbooks into electronic systems, leading to errors, or add timestamps retroactively, violating ALCOA++ requirements (Attributable, Legible, Contemporaneous, Original, Accurate). Data integrity failures occur systematically in environments where people manually transfer data between disconnected systems. Tightening procedures and expanding training alone are insufficient to solve this problem, as data integrity cannot be achieved through training alone. Regulatory readiness must begin with a reassessment of system design, not merely policy revision.